This site is intended for healthcare professionals only
LoginRegister
Fire broke out in solvent reactor at Sahithi Pharma unit, 6 injuredFire broke out in solvent reactor at Sahithi Pharma unit, 6 injured
Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million MarketLupin receives over Rs 205 crore from AbbVie for meeting key product development milestone
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Biologicals gets marketing authorization permission for Adalimumab 40 mg/0.4mL injection in...
US FDA declines to approve Regenerons higher dose EyleaUS FDA declines to approve Regeneron's higher dose Eylea
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma gets CDSCO Panel nod to study Lumateperone Capsules
Granules India inaugurates two advanced Centres of Excellence at IIT HyderabadGranules India warns of significant loss of revenue, profitability due to cyber attack
USFDA nod to JnJ Tremfya for Crohns diseaseCancer plaintiffs drill down on JnJ support for USD 8.9 billion talc deal
GSK concludes acquisition of BELLUS HealthGSK concludes acquisition of BELLUS Health
Pfizer growth hormone drug Ngenla gets USFDA okay for pediatric patientsPfizer growth hormone drug Ngenla gets USFDA okay for pediatric patients
Zydus Lifesciences bags USFDA tentative nod for breast cancer drug PalbociclibZydus Lifesciences bags USFDA tentative nod for breast cancer drug Palbociclib
CDSCO Panel Clears MSN Labs Abiraterone Acetate 1000 mg, Mandates Phase IV TrialMSN Lab Gets CDSCO Panel Nod To Manufacture, Market Vigabatrin Powder for Oral Solution
X